Telomeres are critical for maintaining genomic stability and allowing cells escaping from crisis, and their deregulation has been implicated in cancer and premature aging. To elucidate how telomeres are maintained is therefore important for understanding physiology and pathology of cancer progression and may provide novel therapeutic targets. The major enzyme that replenishes telomeric DNA is telomerase, which is active in most immortalized and transformed/cancer cells, but not in most normal human cells. However, how telomerase activity is regulated is largely unknown. In addition, although telomere maintenance is tightly linked to mitotic progression, the underlying mechanism is unclear. We previously cloned Pini and Pin2 that are critical for mitotic regulation. Pin 1 is a prolyl isomerase that regulates protein conformation and function by isomerizing specific phosphorylated Ser/Thr-Pro bonds. Pin2 is a major telomeric protein almost identical to TRF1, which inhibits telomere elongation but does not directly inhibit telomerase activity. We have shown that Pin2/TPF1 is tightly regulated during the cell cycle and is important for mitotic checkpoint regulation. Our laboratory have further cloned four novel Pin2/TRF1-interacting proteins, PinXl-4, and discovered that PinX1 is the first endogenous telomerase catalytic inhibitor and is a putative tumor suppressor located at 8p23, a region with frequent loss of heterozygosity in a number of cancers. Our preliminary results indicate that Pin2/TRF1 is phosphorylated by Cdc2 in mitosis, which renders Pin2/TRF1 to be a Pini substrate and also disrupts its ability to bind telomeres or PinX3, a novel F-box-containing protein likely involved in ubiquitin-mediated proteolysis. These results led us to propose that Pin2/TRF1 and PinXl are important regulators in telomere maintenance, mitotic regulation and oncogenesis. To test this hypothesis, we will first characterize Pin2/TRF1 ubiquitination and phosphorylation, and determine their roles in mitotic regulation and telomere maintenance. Next, we will determine the role of PinX1 in mediating the inhibitory effect of Pin2/TRF1 on telomere elongation and elucidate how PinX1 inhibits telomerase activity. To evaluate the potential of PinXl as a novel tumor suppressor, we will examine PinX1 genetic mutations in human cancer and their effects on PinXl function, and generate PinXl-deficient mice to determine its in vivo function. Finally, given that PinXl is less potent than its telomerase inhibitory domain in vivo but not in vitro, we will examine how PinX 1 function is regulated. These studies should yield new insights into telomere maintenance, cell growth control and oncogenesis, and may lead to the development of new anticancer therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM056230-06
Application #
6544770
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Zatz, Marion M
Project Start
1997-08-01
Project End
2006-07-31
Budget Start
2002-08-01
Budget End
2003-07-31
Support Year
6
Fiscal Year
2002
Total Cost
$307,230
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Rajbhandari, Prashant; Finn, Greg; Solodin, Natalia M et al. (2012) Regulation of estrogen receptor * N-terminus conformation and function by peptidyl prolyl isomerase Pin1. Mol Cell Biol 32:445-57
Lee, Tae Ho; Chen, Chun-Hau; Suizu, Futoshi et al. (2011) Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. Mol Cell 42:147-59
Balastik, Martin; Lim, Jormay; Pastorino, Lucia et al. (2007) Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism? Biochim Biophys Acta 1772:422-9
Lee, Tae Ho; Perrem, Kilian; Harper, J Wade et al. (2006) The F-box protein FBX4 targets PIN2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance. J Biol Chem 281:759-68
Lu, Kun Ping; Suizu, Futoshi; Zhou, Xiao Zhen et al. (2006) Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Mol Carcinog 45:397-402
Wulf, Gerburg; Finn, Greg; Suizu, Futoshi et al. (2005) Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat Cell Biol 7:435-41
Lim, Jormay; Lu, Kun Ping (2005) Pinning down phosphorylated tau and tauopathies. Biochim Biophys Acta 1739:311-22
Wulf, Gerburg; Garg, Priti; Liou, Yih-Cherng et al. (2004) Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J 23:3397-407
Lu, Kun Ping (2004) Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem Sci 29:200-9
Wulf, Gerburg; Ryo, Akihide; Liou, Yih-Cherng et al. (2003) The prolyl isomerase Pin1 in breast development and cancer. Breast Cancer Res 5:76-82

Showing the most recent 10 out of 36 publications